|Articles|February 8, 2004
How do you measure the quality of life impact by melanoma?
Washington D.C. Sandra Bendeck, M.D. presented at the AADyesterday about ways that physicians can measure the quality of life impactby melanoma. Since the incidence of melanoma is increasing by four percentevery year, it is increasingly important to determine the impact of thisillness on patients, both physically and psychologically.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
Expert Panel Unanimously Backs DecisionDx-Melanoma for Guiding Personalized Cancer Care
4
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
5













